European Market Report for Modern Insulin 2016: Focus on Monitoring, Treatment and Drug Delivery - Research and Markets

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern insulin market was the long-acting insulin segment, which represented nearly 50% of the total market value. Patent expirations and the introduction of new products will lead to higher unit sales growth in this segment, relative to the rapid-acting insulin and premixed insulin segments. Combined with modest appreciation of ASP, it is projected that long-acting insulin will be the fastest growing segment in the total modern insulin market over the forecast period.
DUBLIN, (informazione.it - comunicati stampa - editoria e media)

The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern insulin market was the long-acting insulin segment, which represented nearly 50% of the total market value.

Patent expirations and the introduction of new products will lead to higher unit sales growth in this segment, relative to the rapid-acting insulin and premixed insulin segments. Combined with modest appreciation of ASP, it is projected that long-acting insulin will be the fastest growing segment in the total modern insulin market over the forecast period.

Key Topics Covered:

1. Executive Summary

2. Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems

3. Country Profiles
3.1 Introduction
3.1.1 Population
3.1.2 Gdp Per Capita
3.1.3 Units

Modern Insulin Market
4.1 Introduction
4.1.1 Insulin Types
4.1.1.1 Rapid-Acting Insulin Analogs
4.1.1.2 Regular Human Insulin
4.1.1.3 Intermediate-Acting Insulin Analogs
4.1.1.4 Long-Acting Insulin Analogs
4.1.1.5 Ultra-Long-Acting Insulin Analogs
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Modern Insulin Market
4.3.2 Long-Acting Insulin Market
4.3.3 Rapid-Acting Insulin Market
4.3.4 Premixed Insulin Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

Companies Mentioned

For more information about this report visit http://www.researchandmarkets.com/research/xmc7qv/european_market

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Per maggiori informazioni
Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili